FYI ...

1.8 million

Estimated number of soft tissue filler procedures
in 2010

Source: American Society
of Plastic Surgeons

Connect to Us

Digital Edition

FDA OKs Xeomin for frown lines

Washington — The Food and Drug Administration has approved Xeomin (incobotulinumtoxinA, Merz Aesthetics) for temporary improvement of moderate to severe glabellar lines, Medscape Today reports. Read full article.

Confirm your e-newsletter subscription click here.

To ensure future delivery of email newsletters from
Dermatology Times please take a moment to confirm your subscription by clicking here.
Thank you,
Dermatology Times Staff

Study sees low 'D' in PsA patients

Toronto — Patients with psoriatic arthritis (PsA) have a high prevalence of vitamin D insufficiency, HealthDay News reports. Read full article.

Valeant acquires Ortho, Dermik

Toronto — Valeant Pharmaceuticals, based here, has agreed to buy the Ortho Dermatologics division of Janssen Pharmaceuticals for $345 million, thestar.com reports. Read full article.

FDA to regulate mobile health apps

Washington — The Food and Drug Administration (FDA) has proposed its first regulations for health-related smartphone and wireless tablet applications, or apps, The Washington Post reports. Read full article.

Career Opportunities

All Island Dermatology	Andrew Kaufman
Arizona Skin & Laser	Arizona Skin & Laser
Dr. Ira Schlesinger	Dartmouth Hitchcock Medical Center
Greenville Hospital System	Mark Burnett MD
Plastic Surgery of Southern CT	Richard G Glogau

Contact Us

Contact a Dermatology Times editor Click Here
Contact a Dermatology Times sales representative Click Here
Learn about direct mail, reprints and classifieds in Dermatology Times Click Here

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.